BSE Live
Nov 14, 16:01Prev. Close
5722.20
Open Price
5768.05
Bid Price (Qty.)
5636.00 (1)
Offer Price (Qty.)
5874.40 (9)
NSE Live
Nov 14, 15:53Prev. Close
5725.50
Open Price
5800.50
Bid Price (Qty.)
5722.50 (35)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Alkem Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 461.55 | 436.21 | 481.98 | 459.70 | 357.34 | |
| Net CashFlow From Operating Activities | 241.57 | 264.28 | 96.93 | 151.50 | 197.59 | |
| Net Cash Used In Investing Activities | -259.86 | 119.20 | -349.29 | -278.78 | -723.47 | |
| Net Cash Used From Financing Activities | 25.95 | -395.16 | 273.72 | 19.38 | 624.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.09 | 0.00 | 0.07 | -0.01 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 7.66 | -11.59 | 21.36 | -107.83 | 98.89 | |
| Cash And Cash Equivalents Begin of Year | 17.29 | 28.88 | 7.51 | 115.34 | 16.45 | |
| Cash And Cash Equivalents End Of Year | 24.95 | 17.29 | 28.87 | 7.51 | 115.34 |
11.11.2025
29.09.2025
23.09.2025
19.09.2025
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.06.2025
Alkem Lab Standalone March 2025 Net Sales at Rs 2,044.94 crore, down 13.55% Y-o-Y
05.06.2025
Alkem Lab Consolidated March 2025 Net Sales at Rs 3,143.75 crore, up 7.08% Y-o-Y
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key